Position in WGS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$347,558
New position
Shares Held
5,412
first reported quarter
Ownership
0.018%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Bridgefront Capital, LLC holds $5,984,337 across 11 Diagnostics & Research names. WGS ranks #7 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,644 | $1,791,135 | |
| 2 | DHR |
Danaher Corp /De/
|
5,407 | $1,025,167 | |
| 3 | A |
Agilent Technologies, Inc.
|
6,308 | $718,985 | |
| 4 | ILMN |
Illumina, Inc.
|
4,174 | $514,487 | |
| 5 | RVTY |
Revvity, Inc.
|
4,790 | $419,651 | |
| 6 | QGEN |
Qiagen N.V.
|
9,268 | $371,090 | |
| 7 | WGS |
GeneDx Holdings Corp.
This page
|
5,412 | $347,558 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
476 | $267,459 |
All Filings in WGS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $347,558 | 5,412 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||